Association Between Active Pulmonary Tuberculosis and Circulating MicroRNAs: a Preliminary Study from Turkey

Overview

Journal Turk J Med Sci

Specialty General Medicine

Date 2021 Apr 16

PMID 33862668

Authors

Fatma Kalayci Yuksek

Cenk Kig

GOnenc OrtakOylu

Meltem Uzun

Affiliations

Soon will be listed here.

Abstract

Background/aim: Tuberculosis is a public health problem that still remains significant. For prevention, diagnosis, and treatment of tuberculosis more effective novel biomarkers are needed. MicroRNAs can regulate innate and adaptive immune responses, alter host-pathogen interactions, and affect progression of diseases. The relationship between microRNA expression and active pulmonary tuberculosis (APT) has not yet been investigated in the Turkish population. We aimed to test the potential diagnostic value of some microRNAs whose levels were previously reported to be altered in APT patients.

Materials And Methods: Using two different references (U6 and miR-93), we compared the expression levels of potentially important microRNAs in serum of APT patients with healthy individuals using quantitative polymerase chain reaction (qPCR).

Results: miR-144 expression level was down-regulated in APT patients when either U6 or miR-93 was used for normalization. When data was normalized with miR-93, a statistically significant decrease in miR-125b (0.8 fold) and miR-146a (0.7 fold) expression levels were observed, while no differences were detected for U6. The receiver operating characteristic suggested that miR-144 may be a candidate biomarker for discriminating APT patients and controls (p < 0.05) both for U6 and miR-93.

Conclusion: These findings suggest that miR-144 can have potential as a biomarker for APT. Using a single reference may be misleading in evaluation of microRNA expression. U6 and miR-93 can be used in combination as references for normalization of serum microRNA expression data.

References

Fu Y, Yi Z, Li J, Li R . Deregulated microRNAs in CD4+ T cells from individuals with latent tuberculosis versus active tuberculosis. J Cell Mol Med. 2013; 18(3):503-13. PMC: 3955156. DOI: 10.1111/jcmm.12205. View

Aigner A . MicroRNAs (miRNAs) in cancer invasion and metastasis: therapeutic approaches based on metastasis-related miRNAs. J Mol Med (Berl). 2011; 89(5):445-57. DOI: 10.1007/s00109-010-0716-0. View

Thangappah R, Paramasivan C, Narayanan S . Evaluating PCR, culture & histopathology in the diagnosis of female genital tuberculosis. Indian J Med Res. 2011; 134:40-6. PMC: 3171916. View

Barry S, Chan B, Ellis M, Yang Y, Plit M, Guan G . Identification of miR-93 as a suitable miR for normalizing miRNA in plasma of tuberculosis patients. J Cell Mol Med. 2015; 19(7):1606-13. PMC: 4511358. DOI: 10.1111/jcmm.12535. View

Lv Y, Guo S, Li X, Chi J, Qu Y, Zhong H . Sputum and serum microRNA-144 levels in patients with tuberculosis before and after treatment. Int J Infect Dis. 2016; 43:68-73. DOI: 10.1016/j.ijid.2015.12.014. View

Huang J, Jiao J, Xu W, Zhao H, Zhang C, Shi Y . MiR-155 is upregulated in patients with active tuberculosis and inhibits apoptosis of monocytes by targeting FOXO3. Mol Med Rep. 2015; 12(5):7102-8. DOI: 10.3892/mmr.2015.4250. View

Correia C, Nalpas N, McLoughlin K, Browne J, Gordon S, MacHugh D . Circulating microRNAs as Potential Biomarkers of Infectious Disease. Front Immunol. 2017; 8:118. PMC: 5311051. DOI: 10.3389/fimmu.2017.00118. View

Fabian M, Sonenberg N, Filipowicz W . Regulation of mRNA translation and stability by microRNAs. Annu Rev Biochem. 2010; 79:351-79. DOI: 10.1146/annurev-biochem-060308-103103. View

Wang C, Yang S, Sun G, Tang X, Lu S, Neyrolles O . Comparative miRNA expression profiles in individuals with latent and active tuberculosis. PLoS One. 2011; 6(10):e25832. PMC: 3189221. DOI: 10.1371/journal.pone.0025832. View

10.

Wu L, Lee S, Huang K, Lee T, Hsu P, Weng J . Systematic expression profiling analysis identifies specific microRNA-gene interactions that may differentiate between active and latent tuberculosis infection. Biomed Res Int. 2014; 2014:895179. PMC: 4167957. DOI: 10.1155/2014/895179. View

11.

Pan D, Pan M, Xu Y . Mir-29a expressions in peripheral blood mononuclear cell and cerebrospinal fluid: Diagnostic value in patients with pediatric tuberculous meningitis. Brain Res Bull. 2017; 130:231-235. DOI: 10.1016/j.brainresbull.2017.01.013. View

12.

Kleinsteuber K, Heesch K, Schattling S, Kohns M, Sander-Julch C, Walzl G . Decreased expression of miR-21, miR-26a, miR-29a, and miR-142-3p in CD4⁺ T cells and peripheral blood from tuberculosis patients. PLoS One. 2013; 8(4):e61609. PMC: 3628900. DOI: 10.1371/journal.pone.0061609. View

13.

Liu Y, Jiang J, Wang X, Zhai F, Cheng X . miR-582-5p is upregulated in patients with active tuberculosis and inhibits apoptosis of monocytes by targeting FOXO1. PLoS One. 2013; 8(10):e78381. PMC: 3813442. DOI: 10.1371/journal.pone.0078381. View

14.

Ndzi E, Nkenfou C, Mekue L, Zentilin L, Tamgue O, Pefura E . MicroRNA hsa-miR-29a-3p is a plasma biomarker for the differential diagnosis and monitoring of tuberculosis. Tuberculosis (Edinb). 2019; 114:69-76. DOI: 10.1016/j.tube.2018.12.001. View

15.

Cui J, Liang H, Pan X, Li D, Jiao N, Liu Y . Characterization of a novel panel of plasma microRNAs that discriminates between Mycobacterium tuberculosis infection and healthy individuals. PLoS One. 2017; 12(9):e0184113. PMC: 5598944. DOI: 10.1371/journal.pone.0184113. View

16.

Ueberberg B, Kohns M, Mayatepek E, Jacobsen M . Are microRNAs suitable biomarkers of immunity to tuberculosis?. Mol Cell Pediatr. 2015; 1(1):8. PMC: 4530568. DOI: 10.1186/s40348-014-0008-9. View

17.

Beveridge N, Cairns M . MicroRNA dysregulation in schizophrenia. Neurobiol Dis. 2011; 46(2):263-71. DOI: 10.1016/j.nbd.2011.12.029. View

18.

Yi Z, Fu Y, Ji R, Li R, Guan Z . Altered microRNA signatures in sputum of patients with active pulmonary tuberculosis. PLoS One. 2012; 7(8):e43184. PMC: 3416796. DOI: 10.1371/journal.pone.0043184. View

19.

Yao Q, Chen Y, Zhou X . The roles of microRNAs in epigenetic regulation. Curr Opin Chem Biol. 2019; 51:11-17. DOI: 10.1016/j.cbpa.2019.01.024. View

20.

Yang T, Ge B . miRNAs in immune responses to Mycobacterium tuberculosis infection. Cancer Lett. 2018; 431:22-30. DOI: 10.1016/j.canlet.2018.05.028. View